CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($) $ in Millions	Total	Common Stock	Additional Paid-in Capital	Retained Earnings
Beginning balance (in shares) at Dec. 31, 2023		130,789,936
Beginning balance at Dec. 31, 2023	$ 10,729	$ 1	$ 5,754	$ 4,974
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation (in shares)		168,538
Share-based compensation	4		4
Issuance of common stock for warrant exercise (in shares)		201
Issuance of common stock for warrant exercise	0
Net income (loss)	26			26
Dividends on common stock	(77)			(77)
Ending balance (in shares) at Mar. 31, 2024		130,958,675
Ending balance at Mar. 31, 2024	10,682	$ 1	5,758	4,923
Beginning balance (in shares) at Dec. 31, 2023		130,789,936
Beginning balance at Dec. 31, 2023	10,729	$ 1	5,754	4,974
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(201)
Ending balance (in shares) at Jun. 30, 2024		131,252,107
Ending balance at Jun. 30, 2024	10,370	$ 1	5,768	4,601
Beginning balance (in shares) at Mar. 31, 2024		130,958,675
Beginning balance at Mar. 31, 2024	10,682	$ 1	5,758	4,923
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation (in shares)		264,072
Share-based compensation	9		9
Issuance of common stock for warrant exercise (in shares)		29,360
Issuance of common stock for warrant exercise	1		1
Net income (loss)	(227)			(227)
Dividends on common stock	(95)			(95)
Ending balance (in shares) at Jun. 30, 2024		131,252,107
Ending balance at Jun. 30, 2024	10,370	$ 1	5,768	4,601
Beginning balance (in shares) at Dec. 31, 2024		231,769,886
Beginning balance at Dec. 31, 2024	17,565	$ 2	13,687	3,876
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation (in shares)		386,025
Share-based compensation	(8)		(8)
Issuance of common stock for warrant exercise (in shares)		5,320,216
Issuance of common stock for warrant exercise	21		21
Net income (loss)	(249)			(249)
Dividends on common stock	(138)			(138)
Ending balance (in shares) at Mar. 31, 2025		237,476,127
Ending balance at Mar. 31, 2025	17,191	$ 2	13,700	3,489
Beginning balance (in shares) at Dec. 31, 2024		231,769,886
Beginning balance at Dec. 31, 2024	17,565	$ 2	13,687	3,876
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	719
Ending balance (in shares) at Jun. 30, 2025		237,437,223
Ending balance at Jun. 30, 2025	17,937	$ 2	13,716	4,219
Beginning balance (in shares) at Mar. 31, 2025		237,476,127
Beginning balance at Mar. 31, 2025	17,191	$ 2	13,700	3,489
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation (in shares)		100,820
Share-based compensation	15		15
Issuance of common stock for warrant exercise (in shares)		711,937
Issuance of common stock for warrant exercise	1		1
Repurchase and retirement of common stock (in shares)		(851,661)
Repurchase and retirement of common stock	(100)			(100)
Net income (loss)	968			968
Dividends on common stock	(138)			(138)
Ending balance (in shares) at Jun. 30, 2025		237,437,223
Ending balance at Jun. 30, 2025	$ 17,937	$ 2	$ 13,716	$ 4,219